SCHEMBL29567219

SCHEMBL29567219

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2cccc(N3CCN(C)CC3)c2)c1C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 3/20 0.42
▸ HTR1A P08908 2/20 0.42
▸ HTR2A P28223 2/20 0.42
▸ HTR2C P28335 2/20 0.42
▸ DRD3 P35462 2/20 0.42
▸ HTR6 P50406 2/20 0.42
▸ RAD52 P43351 2/20 0.40
▸ BRD4 O60885 2/20 0.38
▸ GUSB P08236 1/20 0.37
▸ TNK2 Q07912 1/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ EGFR P00533 4/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ CTSC P53634 1/20 0.35
▸ IGF1R P08069 1/20 0.35
▸ NUAK1 O60285 1/20 0.35
▸ NUAK2 Q9H093 1/20 0.35
▸ MAP4K1 Q92918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309381 1.00 HTR7 (0.42) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL26808930 0.92 HTR1A (0.41) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL29566298 0.92 HTR2C (0.41) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL29567464 0.92 HTR1A (0.41) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL24310431 0.92 HTR2C (0.41) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL26808712 0.92 HTR7 (0.41) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL26811481 0.92 HTR2C (0.40) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL24310151 0.91 HTR1A (0.40) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL29566980 0.91 HTR1A (0.40) HTR7HTR1AHTR2AHTR2CDRD3
SCHEMBL24310685 0.90 HTR2C (0.39) HTR7HTR1AHTR2AHTR2CDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback